USD10
BLTE acciones
Acerca de Belite BioBelite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
USD10
BLTE acciones
Acerca de Belite BioBelite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
24 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
5945,84 M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
49,00 US$
ALTO (1Y)
200,00 US$
BAJO (24H)
150,51 US$
Alza (24H)
158,68 US$
Volumen (24 h)
60,26 mil US$
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | No hay suficientes datos | No hay suficientes datos |
1 día | 155,66 US$ | |
1 semana | 165,44 US$ | |
1 mes | 189,46 US$ | |
1 año | 64,50 US$ |
Una nueva era de Coinbase ha comenzado
El futuro del dinero está aquí. Sé uno de los primeros en obtener acceso y probar nuevas funciones en cuanto estén disponibles.
Crea una cuenta ahora